THC Stock Analysis: Buy, Sell, or Hold?
THC - Tenet Healthcare Corporation New
$198.55
2.69 (1.37%)
▲
5d:
+2.28%
30d:
+2.58%
90d:
-14.51%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Smart Money Accumulation
THC is down 6.0% this week, but smart money is accumulating calls. Top strike: $210 2026-06-18 with 513 OI. Call ratio: 62% View Scanner →
Strength: 5.2/10
Get Alerted When THC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: THC shows positive signals but monitor for confirmation. Market pricing in 2.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: THC shows positive signals but monitor for confirmation. Market pricing in 2.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$330.53
Based on 9.4% avg growth
INTRINSIC VALUE TODAY
$205.24
3.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: THC is currently trading at $198.55, which is considered extended relative to its 30-day fair value range of $184.18 to $196.99. The stock's valuation (Forward PE: 11.1) is in line with its historical norms (11.9). Remarkably, the market is currently pricing in an annual earnings decline of 2.1% over the next few years. This pessimistic expectation contrasts with the company's recent 87.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, THC is in a downtrend. The price is approaching resistance at $200.89. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: THC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $245.52 (+23.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, THC is in a downtrend. The price is approaching resistance at $200.89. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: THC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $245.52 (+23.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$184.18 -
$196.99
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.7% below Wall St target ($245.52)
Trading Range Analysis
30-Day Trading Range
$184.18 -
$196.99
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$177.41
Resistance Level
$200.89
Current Trend
Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.14
Wall Street Target
$245.52
(+23.7%)
Revenue Growth (YoY)
2.8%
Earnings Growth (YoY)
87.6%
Profit Margin
7.9%
Valuation Discount vs History
-2.1% cheaper
PE vs Historical
11.1 vs 11.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.1%
(market-implied from PE analysis)
1-Year Target
$194.38
(-2%)
2-Year Target
$190.30
(-4%)
3-Year Target
$186.30
(-6%)
3-Yr Target (if PE normalizes)
(PE: 11→12)
$198.96
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 14.7%)
$394.45
(+99%)
Base:
(SPY PE: 11.1, Growth: 14.7%)
$199.43
(+0%)
Bear:
(PE: 9.5, Growth: 14.7%)
$169.51
(-15%)
📈
Valuation based on Current Earnings
Trailing PE: 10.18 | Current EPS (TTM): $19.24
Bull Case
$199.53
(+1%)
Analyst growth -7.4%, PE expands to 11.2
Base Case
$181.39
(-9%)
Market implied -7.4%, PE stable at 10.2
Bear Case
$133.18
(-33%)
Severe decline -20.0%, PE contracts to 8.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.1 to 11.9
Stabilization Target:
$212.04
(+6.8%)
PE Expansion Potential:
+6.8%
Share & Embed Analysis
Last updated: May 14, 2026 9:46 PM ET
Data refreshes hourly during market hours. Next update: 10:46 PM
Data refreshes hourly during market hours. Next update: 10:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is THC showing a specific setup today?
Insider Activity (6 Months)
1
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Paola M Arbour
SELL
6500 shares
2026-03-11
Thomas W Arnst
SELL
8000 shares
2026-03-09
R. Scott Ramsey
SELL
8017 shares
2026-03-02
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 66 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 62 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 63 BUY |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$30 | 62 BUY |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 56 HOLD |
Advanced THC Option Strategies
Professional options setups generated by AI based on today's THC price and gamma walls.
